Gastrointestinal flora and gastrointestinal status in children with autism - comparisons to typical children and correlation with autism severity

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Adams, James B ^a   Johansen, Leah J ^a   Powell, Linda D ^a   Quig, David ^b   Rubin, Robert A ^c  

^a Arizona State University   (United States)

^b Doctor's Data   (United States)

^c WHITTIER COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ELASTASE; FISH OIL; LACTOFERRIN; LYSOZYME; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; SHORT CHAIN FATTY ACID; VALERIC ACID; VOLATILE FATTY ACID;

ARTICLE; AUTISM; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; FOOD INTAKE; FUNGUS CULTURE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; PARASITOLOGY; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; SEA FOOD; SEX DIFFERENCE; YEAST; CASE CONTROL STUDY; DIGESTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HOSPITALIZATION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTISTIC DISORDER; BIFIDOBACTERIUM; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIGESTION; FATTY ACIDS, VOLATILE; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS; MALE; PROBIOTICS; SEVERITY OF ILLNESS INDEX;

EID: 79952582127     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-22     Document Type: Article

References (44)

1. Buie T, Fuchs GJ, Furuta GT, Kooros K, Levy J, Lewis JD, Wershil BK, Winter H. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics 2010, 125(Suppl 1):S19-29. 10.1542/peds.2009-1878D, 20048084.
2. Molloy CA, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 2003, 7(2):165-171. 10.1177/1362361303007002004, 12846385.
3. Nikolov Roumen N, Bearss Karen E, Jelle L, Craig E, Maria R, Aman Michael G, McCracken James T, McDougle Christopher J, Elaine T, Benedetto V, Eugene AL, Bhavik S, Posey David J, Louise R, Lawrence S. Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental Disorders. J Autism Dev Disord 2009, 39:405-413. 10.1007/s10803-008-0637-8, 18791817.
4. Xue M, Michael B, Janti C, Barbie Z, Wagner George C. Autism Spectrum Disorders: Concurrent Clinical Disorders. J Child Neurol 2008, 23(1):6-13.
5. Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 2006, 27(2 Suppl):S128-36. 10.1097/00004703-200604002-00011, 16685179.
6. Adams JB, Holloway CE, George F, Quig D. Analyses of Toxic Metals and Essential Minerals in the Hair of Arizona Children with Autism and their mothers. Biol Tr El Res 2006, 110:193-209.
7. Adams JB, Romdalvik J, Ramanujam VMS, Legator MS. Mercury, Lead, and Zinc in Baby Teeth of Children with Autism vs. Controls. J Toxicol Environ Health 2007, 70(12):1046-51.
8. Adams JB, Romdalvik J, Levine KE, Hu L-W. Mercury in First-Cut Baby Hair of Children with Autism vs. Typically-Developing Children. Toxicological and Environmental Chemistry 2008, 90(4):739-753.
9. Konstantareas MM, Homatidis S. Ear infections in autistic and normal-children. Journal of Autism and Developmental Disorders 1987, 17(4):585-594. 10.1007/BF01486973, 3680158.
10. Niehus R, Lord C. Early medical history of children with autism spectrum disorders. Journal of Developmental and Behavioral Pediatrics 2006, 27(2):S120-S127. 10.1097/00004703-200604002-00010, 16685178.
11. Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A. Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases 2002, 35:S6-S16. 10.1086/341914, 12173102.
12. Song YL, CX L, Finegold SA. Real-time PCR quantitation of clostridia in Feces of autistic children. Applied and Environmental Microbiology 2004, 70(11):6459-6465. 10.1128/AEM.70.11.6459-6465.2004, 525120, 15528506.
13. Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology 2005, 54(10):987-991. 10.1099/jmm.0.46101-0, 16157555.
14. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16(4):444-53. 10.1016/j.anaerobe.2010.06.008, 20603222.
15. Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, Nelson MN, Wexler HM. Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology 2000, 15(7):429-435. 10.1177/088307380001500701, 10921511.
16. Finegold SM. Therapy and epidemiology of autism-clostridial spores as key elements. Medical Hypotheses 2008, 70(3):508-511. 10.1016/j.mehy.2007.07.019, 17904761.
17. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP. Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 2007, 176(1):149-69. 10.1016/j.bbr.2006.07.025, 16950524.
18. Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain DP. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism. Neuropharmacology 2008, 54(6):901-911. 10.1016/j.neuropharm.2008.01.013, 18395759.
19. Elsden SR, Hilton MG. Volatile acid production from threonine, valine, leucine and isoleucine by clostridia. Arch Microbiol 1978, 117(2):165-72. 10.1007/BF00402304, 678022.
20. Shultz SR, Macfabe DF, Martin S, Jackson J, Taylor R, Boon F, Ossenkopp KP, Cain DP. Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav Brain Res 2009, 200(1):33-41. 10.1016/j.bbr.2008.12.023, 19154758.
21. Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002, 4(3):251-8. 10.1007/s11894-002-0071-6, 12010627.
22. de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C. Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives. J Pediatr Gastroenterol Nutr http://www.ncbi.nlm.nih.gov/pubmed/20683204.
23. Rimland B, Edelson S. Autism Treatment Evaluation Checklist: Statistical Analyses. 2000, Autism Research Institute, San Diego, CA.
24. Schneider CK, Melmed RD, Barstow LE, Enriquez FJ, Ranger-Moore J, Ostrem JA. Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study. Journal Autism Developmental Disorders 2006, 36(8):1053-64.
25. Reifenstein RW, Gray SJ. The Effect of Adrenocorticotropic Hormone upon the Fecal Lysozyme Titer in Ulcerative Colitis. Gastroenterology 1951, 19(3):547-557.
26. Van Der Sluys Veer A, Brouwer J, Biemond I, Bohbouth GE, Verspaget HW, Lamers CBHW. Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease. Digestive Diseases and Sciences 1998, 43(3):590-595. 10.1023/A:1018823426917, 9539656.
27. Dugad L. Performance Verification of Lysozyme ELISA Test Kit Verification 105. 2007, Doctor's Data, Inc. Saint Charles, Illinois.
28. Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AAM, Cooper WH, Lee AG. Measurement of Fecal Lactoferrin as a Marker of Fecal Leukocytes. Journal of Clinical Microbiology 1992, 30:1238-1242. 265257, 1583125.
29. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal Lactoferrin is a Sensitive and Specific Marker in Identifying Intestinal Inflammation. The American Journal of Gastroenterology 2003, 98(6):1309-1314. 10.1111/j.1572-0241.2003.07458.x, 12818275.
30. Kayazawa M, Saitoh O, Kojima K, Nakagawa K, Tanaka S, Tabata K, Matsuse R, Uchida K, Hoshimoto M, Hirata I, Katsu K. Lactoferrin in Whole Gut Lavage Fluid as a Marker for Disease Activity in Inflammatory Bowel Disease: Comparison with Other Neutrophil-Derived Proteins. The American Journal of Gastroenterology 2002, 97(2):360-369. 10.1111/j.1572-0241.2002.05470.x, 11866274.
31. Fine KD, Ogunji F, George J, Niehaus BA, Guerrant RL. Utility of a Rapid Fecal Latex Agglutination Test Detecting the Neutrophil Protein, Lactoferrin, for Diagnosing Inflammatory Causes of Chronic Diarrhea. The American Journal of Gastroenterology 1998, 93(8):1300-1305. 10.1111/j.1572-0241.1998.413_l.x, 9707055.
32. Dugad L, Wu Z. PerformanceVerification of Lactoferrin ELISA Test Kit of Fecal Verification 104. 2007, Doctor's Data Inc, Saint Charles, Illinois.
33. Kudoh K, Shimizu J, Ishiyama A, Wada M, Takita T, Kanke Y, Innami S. Secretion and Excretion of Immunoglobulin A to Cecum and Feces Differ with Type of Indigestible Saccharides. J Nutr Sci Vitaminol 1999, 45:173-181.
34. Nishio O, Sakae K, Ishihara Y, Isomura S, Inouye S. Adenovirus Infection and Specific Secretory IgA Responses in the Intestine of Infants. Microbiol Immunol 1992, 36(6):623-631.
35. Stals F, Walther F, Bruggeman CA. Faecal and Pharyngeal Shedding of Rotavirus and Rotavirus IgA in Children with Diarrhea. Journal of Medical Virology 1984, 14:333-339. 10.1002/jmv.1890140406, 6096502.
36. Scerpella EG, Gould SS, Mathewson JJ, DuPont HL. Methods for Detection of an Intestinal Secretory Immunoglobulin A Response to Candida spp. and Their Preliminary Application in Human Immunodeficiency Virus-Infected Patients with Chronic Diarrhea. Clinical and Diagnostic Laboratory Immunology 1995, 2(2):246-248. 170138, 7697539.
37. Zarling EJ, Ruchim MA. Protein Origin of the Volatile Fatty Acids Iso-Butyrate and Iso-Valerate in Human Stool. J Lab Clin Med 1987, 109:566-70.
38. Araki Y, Andoh A, Fujiyama Y, Itoh A, Bamba T. In vitro Alterations in Fecal Short Chain Fatty Acids and Organic Anions Induced by the Destruction of Intestinal Microflora under Hypotonic and Aerobic Conditions. Int J Mol Med 2002, 9(6):627-631.
39. Topping DL, Clifton PM. Short Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides. Physiol Reviews 2001, 81(3):1031-1064.
40. Garner Catherine E, Stephen S, de Lacy Costello B, Paul W, Robert S, Probert Chris SJ, Ratcliffe Norman M. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J 2007, 21:1675-1688. 10.1096/fj.06-6927com, 17314143.
41. Collin DP, McCormick PG. Determination of Short Chain Fatty Acids in Stool Ultrafiltrate and Urine. Clin Chem 1974, 20(9):1173-1180.
42. Collin DP, McCormick PG, Schmitt MG. Quantitative Gas-Chromatographic Determination of Short Chain Fatty Acids in Aqueous Samples. Clin Chem 1974, 20(9):1235-1237.
43. Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003, 77(6):1537S-1543S.
44. Edelson S. Parent Ratings of Behavioral Effects of Biomedical Interventions. 2010, Autism Research Institute, Publication 34, San Diego, CA.